“…PET ligands targeting the 18 kDa translocator protein, which is upregulated with inflammation, detect neuroinflammation in human diseases including multiple sclerosis and in animal models, but the effectiveness of these PET markers remains to be seen (Banati et al, 2000;Papadopoulos et al, 2006;Chauveau et al, 2009Chauveau et al, , 2011Abourbeh et al, 2012;Xie et al, 2012). Promising advances in imaging myelination have been reported including myelin water imaging (MacKay et al, 1994;Du et al, 2007;Laule et al, 2008;Hwang et al, 2010;Prasloski et al, 2012), magnetization transfer (Inglese et al, 2003;Schmierer et al, 2004Schmierer et al, , 2007aDortch et al, 2011;Stikov et al, 2011;Underhill et al, 2011), optical imaging (Wang et al, 2011a) and myelin-specific PET markers (Wang et al, 2009;Wu et al, 2013). For specifically identifying axon injury and loss, reduced NAA content measured by magnetic resonance spectroscopy (MRS) has been used (De Stefano et al, 1999;Aboul-Enein et al, 2010;Wood et al, 2012).…”